Dear ICPR friends,
Since postponing ICPR 2020 to September, and staying at home for the better part of our lives, we started feeling a little itchy. We imagined you might too. That’s why we’re excited to announce two panel-style webinars on 15 & 16 May.
Both webinars are free for ICPR 2020 ticket-holders.
For others, access is available at a fee of 12.50€ for one webinar, 20€ for both.
Webinar 1 – The therapeutic mechanisms of psychedelics
Friday 15 May
Starts at 8pm (Amsterdam) | 7pm (London) | 2pm (New York) | 11am (California)
Matt Johnson, Katrin Preller, Ros Watts and Alex Belser will discuss our current understanding of the therapeutic mechanisms of psychedelics. These international experts have a large body of evidence available to them: from clinical observations during therapy sessions, insights from patient interviews, to research findings from cognitive, pharmacological and neuroimaging studies.
This webinar will feature short presentations from each speaker, followed by a discussion moderated by Joost Breeksema, ending with interaction with you, the audience.
Ros Watts, PsyD, is a clinical psychologist and the clinical leader of the Psilocybin for Depression study at Imperial College London. She designed the therapy protocol for Psilodep 2, and works as a lead ‘guide’ alongside three other therapists. Her qualitative research explored the patients’ perspectives, giving rise to the importance of connectedness in psychedelic treatments.
Alex Belser, PhD, is a licensed psychologist based at Yale and New York University. He is a study therapist in a trial of MDMA-assisted psychotherapy for severe PTSD and co-investigator of studies investigating psilocybin-assisted psychotherapy for obsessive-compulsive disorder and major depression. He has also conducted qualitative research on participant’s experiences during a trial into psilocybin-assisted therapy for end-of-life anxiety.
Matt Johnson, PhD is a professor at Johns Hopkins, and an expert on psychedelics, other drugs, and addiction. He has conducted research with psychedelics for over 15 years, and in 2008 provided the frequently cited psychedelic risk and safety guidelines, helping resurrect human psychedelic research. He also published the first research on psychedelic treatment of tobacco addiction and the largest study of psilocybin in treating cancer-related distress.
Katrin Preller, PhD is a neuroscientist based at the University of Zurich, where she uses a variety of brain imaging techniques to investigate the effects of psychedelics on self-perception, social cognition, and multimodal processing. Her group’s research focuses on the neurobiology and pharmacology of cognitive and emotional processes in health and disease.
Webinar 2 – How can we study altered states of consciousness?
Saturday 16 May
Starts at 4pm (Amsterdam) | 3pm (London) | 11am (New York/Buenos Aires) | 7am (California)
This webinar is dedicated to the memory of ALIUS founder Martin Fortier-Davy and features Chris Timmermann, Enzo Tagliazucchi, Katrin Preller, and Raphaël Millière. Each of these researchers use their own set of innovative methods to study the diversity of consciousness. Whether it’s through amassing and analyzing big data sets, scanning the brains of volunteers who are given psychedelics intravenously in laboratory settings, or using specialized interview techniques such as microphenomenology, these researchers all try to capture what it’s like to be in an altered state of consciousness. how this can help us to understand the nature of consciousness, and how we can use this knowledge to improve mental health.
All speakers are asked to reflect upon the following three questions: (1) what is your preferred method for studying ASCs? (2) What are the challenges for a multidisciplinary approach to studying ASCs? And (3) where do you think the field of ASC research will be in 10 years from now?
Raphael Millière: Telling it like it is: how to investigate ASCs through natural language reports
Enzo Tagliazucchi: Computational neuroscience methods for the study of states of consciousness
Christopher Timmermann: Studying Psychedelics and metaphysical beliefs
Katrin Preller: Studying ASCs using Psychedelics